Advisornet Financial’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-13,801
Closed -$1.4M 2289
2025
Q4
$1.4M Sell
13,801
-2,757
-17% -$221K 0.07% 210
2025
Q3
$906K Buy
16,558
+3,115
+23% +$156K 0.05% 269
2025
Q2
$714K Buy
13,443
+1,412
+12% +$71.7K 0.05% 299
2025
Q1
$521K Buy
12,031
+1,052
+10% +$53.3K 0.04% 344
2024
Q4
$617K Sell
10,979
-24
-0.2% -$1.49K 0.05% 271
2024
Q3
$750K Buy
11,003
+30
+0.3% +$1.69K 0.06% 260
2024
Q2
$464K Buy
10,973
+671
+7% +$36.9K 0.04% 317
2024
Q1
$711K Buy
10,302
+1,461
+17% +$92.4K 0.07% 252
2023
Q4
$654K Buy
8,841
+1,257
+17% +$82.4K 0.06% 276
2023
Q3
$517K Sell
7,584
-7
-0.1% -$594 0.05% 299
2023
Q2
$713K Buy
7,591
+1,135
+18% +$88.5K 0.06% 253
2023
Q1
$438K Buy
6,456
+4
+0.1% +$257 0.04% 317
2022
Q4
$319K Buy
6,452
+1,749
+37% +$71.5K 0.03% 379
2022
Q3
$153K Buy
4,703
+2,110
+81% +$87K 0.02% 558
2022
Q2
$102K Sell
2,593
-11,968
-82% -$640K 0.01% 656
2022
Q1
$1.02M Buy
14,561
+2,708
+23% +$198K 0.06% 247
2021
Q4
$923K Buy
11,853
+2,777
+31% +$245K 0.06% 280
2021
Q3
$866K Buy
9,076
+1,640
+22% +$173K 0.06% 255
2021
Q2
$924K Buy
7,436
+495
+7% +$59.1K 0.06% 270
2021
Q1
$915K Sell
6,941
-676
-9% -$92.5K 0.07% 253
2020
Q4
$1.01M Sell
7,617
-669
-8% -$80.9K 0.08% 218
2020
Q3
$845K Sell
8,286
-2,084
-20% -$180K 0.07% 240
2020
Q2
$902K Sell
10,370
-5,399
-34% -$431K 0.07% 236
2020
Q1
$915K Buy
15,769
+2,729
+21% +$222K 0.08% 204
2019
Q4
$1.21M Buy
13,040
+1,792
+16% +$158K 0.1% 186
2019
Q3
$1.02M Sell
11,248
-2,564
-19% -$292K 0.09% 213
2019
Q2
$1.63M Sell
13,812
-4,490
-25% -$452K 0.18% 123
2019
Q1
$1.58M Sell
18,302
-7,175
-28% -$611K 0.19% 117
2018
Q4
$1.61M Sell
25,477
-1,185
-4% -$81.3K 0.22% 98
2018
Q3
$2.1M Sell
26,662
-2,913
-10% -$190K 0.26% 81
2018
Q2
$1.77M Sell
29,575
-985
-3% -$53K 0.24% 87
2018
Q1
$1.23M Buy
30,560
+920
+3% +$44.9K 0.17% 115
2017
Q4
$1.56M Buy
+29,640
New +$1.58M 0.24% 88

Other funds holding EXAS

Advisornet Financial's EXAS Position: Q1 2026 in Review

Advisornet Financial sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 13,801 shares — an estimated $1.4M sold.

Advisornet Financial first reported a position in EXAS in Q4 2017 and held it in 33 quarters. The position peaked at $2.1M in Q3 2018. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Advisornet Financial reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Advisornet Financial sold 13,801 Exact Sciences shares in Q1 2026, an estimated $1.4M.
  • Advisornet Financial first reported a position in Exact Sciences in Q4 2017 and held it in 33 quarters.
  • Advisornet Financial's Exact Sciences position peaked at $2.1M in Q3 2018.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Advisornet Financial's 13F filing for Q1 2026, filed 17 Apr 2026.